Jan 12, 2025, 06:45
Richard Buka: TPO-RA – Sustained Responses in ITP After Stopping Treatment
Richard Buka, Chair of HaemSTAR, shared a post on X about a paper by Adrien Cottu et al. published in Blood Journal:
“Important study in Blood Journal. Of 48 patients with ITP who achieved full response to TPO-RA for a year, then stopped, half maintained that response at 4 years.
Demonstrates immunomodulatory effects of TPO-RA and supports consideration for stopping rx in patients stable for 1 year.”
“Long-term Follow-up of the STOPAGO Study”
Authors: Adrien Cottu, Stéphanie Guillet, Jean-François Viallard, Bertrand Godeau, Matthieu Mahevas et al.
More posts featuring Richard Buka.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 12, 2025, 06:45
Jan 12, 2025, 06:34
Jan 11, 2025, 21:25
Jan 11, 2025, 21:11
Jan 11, 2025, 21:09
Jan 11, 2025, 17:09